AR008395A1 - COMPOUND DERIVED FROM PIRIMIDINE, PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS IT, PROCEDURE TO PREPARE IT, AND INTERMEDIATE COMPOUND USEFUL TO CARRY OUT SUCH PROCEDURE. - Google Patents

COMPOUND DERIVED FROM PIRIMIDINE, PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS IT, PROCEDURE TO PREPARE IT, AND INTERMEDIATE COMPOUND USEFUL TO CARRY OUT SUCH PROCEDURE.

Info

Publication number
AR008395A1
AR008395A1 ARP970102801A ARP970102801A AR008395A1 AR 008395 A1 AR008395 A1 AR 008395A1 AR P970102801 A ARP970102801 A AR P970102801A AR P970102801 A ARP970102801 A AR P970102801A AR 008395 A1 AR008395 A1 AR 008395A1
Authority
AR
Argentina
Prior art keywords
procedure
pharmaceutical composition
pirimidine
understands
prepare
Prior art date
Application number
ARP970102801A
Other languages
Spanish (es)
Original Assignee
Astra Pharma Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9614360.7A external-priority patent/GB9614360D0/en
Priority claimed from GBGB9626884.2A external-priority patent/GB9626884D0/en
Application filed by Astra Pharma Prod filed Critical Astra Pharma Prod
Publication of AR008395A1 publication Critical patent/AR008395A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Un compuesto derivado de pirimidina que tiene la formula I donde R, Ar1, W, X, Y y Z son como se definen en la memoria descriptiva. Además, se dan aconocer una composicion farmacéutica que comprende a dicho compuesto, un procedimiento para prepararlo, y un compuesto intermediario util para llevar acabo dicho procedimiento.A pyrimidine derived compound having formula I where R, Ar1, W, X, Y and Z are as defined in the specification. In addition, a pharmaceutical composition comprising said compound, a process for preparing it, and an intermediate useful for carrying out said process are disclosed.

ARP970102801A 1996-07-09 1997-06-25 COMPOUND DERIVED FROM PIRIMIDINE, PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS IT, PROCEDURE TO PREPARE IT, AND INTERMEDIATE COMPOUND USEFUL TO CARRY OUT SUCH PROCEDURE. AR008395A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9614360.7A GB9614360D0 (en) 1996-07-09 1996-07-09 Compounds
GBGB9626884.2A GB9626884D0 (en) 1996-12-24 1996-12-24 Compounds

Publications (1)

Publication Number Publication Date
AR008395A1 true AR008395A1 (en) 2000-01-19

Family

ID=26309668

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970102801A AR008395A1 (en) 1996-07-09 1997-06-25 COMPOUND DERIVED FROM PIRIMIDINE, PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS IT, PROCEDURE TO PREPARE IT, AND INTERMEDIATE COMPOUND USEFUL TO CARRY OUT SUCH PROCEDURE.

Country Status (16)

Country Link
EP (1) EP0915879A1 (en)
JP (1) JP2000516206A (en)
KR (1) KR20000023644A (en)
AR (1) AR008395A1 (en)
AU (1) AU708882B2 (en)
BR (1) BR9710215A (en)
CA (1) CA2260057A1 (en)
CZ (1) CZ3699A3 (en)
EE (1) EE9900012A (en)
ID (1) ID18889A (en)
IL (1) IL127690A0 (en)
IS (1) IS4932A (en)
NO (1) NO990072D0 (en)
PL (1) PL331090A1 (en)
TR (1) TR199900013T2 (en)
WO (1) WO1998001449A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL160327A0 (en) * 2001-08-13 2004-07-25 Janssen Pharmaceutica Nv 2,4,5-trisubstituted thiazolyl derivatives and their antiinflammatory activity
US8686139B2 (en) 2009-11-24 2014-04-01 Novaled Ag Organic electronic device comprising an organic semiconducting material
WO2014084612A1 (en) 2012-11-30 2014-06-05 주식회사 엘지화학 Novel compound and organic electronic element using same
KR102153040B1 (en) 2013-11-28 2020-09-07 삼성전자주식회사 Condensed cyclic compound and organic light emitting diode including the same
EP3445244A4 (en) 2016-04-22 2019-12-11 Vioptix, Inc. Determining absolute and relative tissue oxygen saturation
CN108484606B (en) * 2018-03-16 2020-03-06 江南大学 Pyrimido [4,5-f ] quinazoline compound and application thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670577A1 (en) * 1967-10-05 1971-05-19 Akad Wissenschaften Ddr Process for the preparation of 5-oxo-5.6.7.8-tetrahydro-chinazelinen
US4272535A (en) * 1978-07-31 1981-06-09 Schering Corporation 2,4-[1H,3H,5H]-(1)-Benzopyrano-[2,3-d]-pyrimidinediones and their use as anti-allergy agents
US4762843A (en) * 1986-09-15 1988-08-09 Warner-Lambert Company Hetero [f] fused carbocyclic pyridines as dopaminergic agents
US5597823A (en) * 1995-01-27 1997-01-28 Abbott Laboratories Tricyclic substituted hexahydrobenz [e]isoindole alpha-1 adrenergic antagonists

Also Published As

Publication number Publication date
KR20000023644A (en) 2000-04-25
EE9900012A (en) 1999-06-15
IS4932A (en) 1998-12-23
WO1998001449A1 (en) 1998-01-15
TR199900013T2 (en) 1999-04-21
PL331090A1 (en) 1999-06-21
IL127690A0 (en) 1999-10-28
AU708882B2 (en) 1999-08-12
BR9710215A (en) 1999-08-10
CZ3699A3 (en) 1999-06-16
ID18889A (en) 1998-05-20
CA2260057A1 (en) 1998-01-15
NO990072D0 (en) 1999-01-08
EP0915879A1 (en) 1999-05-19
JP2000516206A (en) 2000-12-05
AU3711697A (en) 1998-02-02

Similar Documents

Publication Publication Date Title
BR9906934B1 (en) compound, catalyst, process for preparing a polyolefin, and use of a catalyst.
ES2195970T3 (en) L-RIBAVIRINA AND USES OF THE SAME.
SV1996000114A (en) NEW PESTICIDES
MY126559A (en) Fungicidal 2-methoxybenzophenones
TR200000782T2 (en) Resorcinol derivatives.
DE69812375D1 (en) COMMUNICATION NETWORK WORKING ACCORDING TO THE CONNECTIVE PRINCIPLE
ID23374A (en) HALOGENOPIRIMIDIN
BR9915708B1 (en) process for preparing monoaryloxy metallocenes.
DE69824841D1 (en) COMMUNICATION NETWORK WORKING ACCORDING TO THE CONNECTIVE PRINCIPLE
ES2193102T3 (en) IMIDOCROME COMPOUNDS IN CATALYST SYSTEMS FOR OLEFIN POLYMERIZATION.
TR200003390T2 (en) 2- (2-Methylphenyl) -3,4-dihydro-2H-pyrrole derivatives
AR008395A1 (en) COMPOUND DERIVED FROM PIRIMIDINE, PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS IT, PROCEDURE TO PREPARE IT, AND INTERMEDIATE COMPOUND USEFUL TO CARRY OUT SUCH PROCEDURE.
BR9902084A (en) Heterocycles.
MX195932B (en) Powder coating compositions, including extended isocyanurates as curing agents
IT1293777B1 (en) PROCESS FOR THE PREPARATION OF TETRAAZAMACROCYCLES
ES2166045T3 (en) PROCEDURE FOR THE PREPARATION OF 4,6-BIS COMPOUNDS (ARILOXI) ASYMMETRIC PYRIMIDINE.
BR0114884A (en) Calcally Compounds
EA199900740A1 (en) METHOD OF OBTAINING EPROSARTAN (OPTIONS)
EP1189909A4 (en) Novel aluminosiloxane compound and process for preparing the same
NO20002024D0 (en) Bisquaternary ammonium derivatives as neuromuscular relaxants
DK1075473T3 (en) Process for the preparation of 1,3-disubstituted-4-oxocyclic ureas
DK0800506T3 (en) Solvent-free process for preparing 2,6-diflourbenzonitrile
BR9710386B1 (en) compound preparation process and compound transformation process.
PL313594A1 (en) Triaryl ethylene derivatives for therapeutic applications
BRPI0017522B8 (en) process for preparing polymorph and growth hormone secretagogues